[New Recommendations on Palliative Sedation]

Overview

Journal Schmerz

Date 2024 Sep 12

PMID 39264452

Authors

Severine Marie Surges

Holger Brunsch

Marta Przyborek

Birgit Jaspers

Lukas Radbruch

Affiliations

Soon will be listed here.

Abstract

Palliative sedation aims to relieve refractory suffering in patients with life-limiting disease. The 2009 framework on palliative sedation of the European Association for Palliative Care (EAPC) has recently been updated. Recommendations have also been formulated by the research group SedPall in Germany. This article describes the social and ethical complexity of decision-making and summarises the recommendations. Patient autonomy is emphasised. Refractoriness of the suffering should be determined jointly by physician and patient. Sedation should be proportional, that is to say, its form and duration should be adapted to the patient's individual situation. The decision on palliative sedation and that on hydration involve two separate decision-making processes. Midazolam should be used as first choice. Particular attention should be paid to the patient's relatives/significant others and the treating team.

References

Chochinov H, Hassard T, McClement S, Hack T, Kristjanson L, Harlos M . The landscape of distress in the terminally ill. J Pain Symptom Manage. 2009; 38(5):641-9. DOI: 10.1016/j.jpainsymman.2009.04.021. View

Surges S, Garralda E, Jaspers B, Brunsch H, Rijpstra M, Hasselaar J . Review of European Guidelines on Palliative Sedation: A Foundation for the Updating of the European Association for Palliative Care Framework. J Palliat Med. 2022; 25(11):1721-1731. DOI: 10.1089/jpm.2021.0646. View

Park S, Ahn H, Ahn H, Han K, Hwang I . Association between continuous deep sedation and survival time in terminally ill cancer patients. Support Care Cancer. 2020; 29(1):525-531. DOI: 10.1007/s00520-020-05516-8. View

Ostgathe C, Bausewein C, Schildmann E, Bazata J, Handtke V, Heckel M . Expert-approved best practice recommendations on the use of sedative drugs and intentional sedation in specialist palliative care (SedPall). BMC Palliat Care. 2023; 22(1):126. PMC: 10476406. DOI: 10.1186/s12904-023-01243-z. View

Fritzson A, Tavelin B, Axelsson B . Association between parenteral fluids and symptoms in hospital end-of-life care: an observational study of 280 patients. BMJ Support Palliat Care. 2014; 5(2):160-8. DOI: 10.1136/bmjspcare-2013-000501. View

Arantzamendi M, Belar A, Payne S, Rijpstra M, Preston N, Menten J . Clinical Aspects of Palliative Sedation in Prospective Studies. A Systematic Review. J Pain Symptom Manage. 2020; 61(4):831-844.e10. DOI: 10.1016/j.jpainsymman.2020.09.022. View

Gabl C, Feichtner A, Weixler D . Sedation indicated?-rethinking existential suffering: a narrative review. Ann Palliat Med. 2024; 13(2):397-414. DOI: 10.21037/apm-23-474. View

Wu C, Chen P, Ho T, Lin W, Cheng S . To hydrate or not to hydrate? The effect of hydration on survival, symptoms and quality of dying among terminally ill cancer patients. BMC Palliat Care. 2021; 20(1):13. PMC: 7805082. DOI: 10.1186/s12904-021-00710-9. View

Cherny N, Radbruch L . European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med. 2009; 23(7):581-93. DOI: 10.1177/0269216309107024. View

10.

Maeda I, Morita T, Yamaguchi T, Inoue S, Ikenaga M, Matsumoto Y . Effect of continuous deep sedation on survival in patients with advanced cancer (J-Proval): a propensity score-weighted analysis of a prospective cohort study. Lancet Oncol. 2015; 17(1):115-22. DOI: 10.1016/S1470-2045(15)00401-5. View

11.

Cohen M, Torres-Vigil I, Burbach B, de la Rosa A, Bruera E . The meaning of parenteral hydration to family caregivers and patients with advanced cancer receiving hospice care. J Pain Symptom Manage. 2012; 43(5):855-65. PMC: 3354988. DOI: 10.1016/j.jpainsymman.2011.06.016. View

12.

Steinhauser K, Christakis N, Clipp E, McNeilly M, McIntyre L, Tulsky J . Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA. 2000; 284(19):2476-82. DOI: 10.1001/jama.284.19.2476. View

13.

Kremling A, Bausewein C, Klein C, Schildmann E, Ostgathe C, Ziegler K . Intentional Sedation as a Means to Ease Suffering: A Systematically Constructed Terminology for Sedation in Palliative Care. J Palliat Med. 2022; 25(5):793-796. PMC: 9081045. DOI: 10.1089/jpm.2021.0428. View

14.

Bush S, Grassau P, Yarmo M, Zhang T, Zinkie S, Pereira J . The Richmond Agitation-Sedation Scale modified for palliative care inpatients (RASS-PAL): a pilot study exploring validity and feasibility in clinical practice. BMC Palliat Care. 2014; 13(1):17. PMC: 3997822. DOI: 10.1186/1472-684X-13-17. View

15.

Belar A, Arantzamendi M, Payne S, Preston N, Rijpstra M, Hasselaar J . How to measure the effects and potential adverse events of palliative sedation? An integrative review. Palliat Med. 2020; 35(2):295-314. PMC: 7897792. DOI: 10.1177/0269216320974264. View

16.

Belar A, Arantzamendi M, Menten J, Payne S, Hasselaar J, Centeno C . The Decision-Making Process for Palliative Sedation for Patients with Advanced Cancer-Analysis from a Systematic Review of Prospective Studies. Cancers (Basel). 2022; 14(2). PMC: 8773810. DOI: 10.3390/cancers14020301. View

17.

Bozzaro C, Schildmann J . "Suffering" in Palliative Sedation: Conceptual Analysis and Implications for Decision Making in Clinical Practice. J Pain Symptom Manage. 2018; 56(2):288-294. DOI: 10.1016/j.jpainsymman.2018.04.003. View

18.

Surges S, Brunsch H, Jaspers B, Apostolidis K, Cardone A, Centeno C . Revised European Association for Palliative Care (EAPC) recommended framework on palliative sedation: An international Delphi study. Palliat Med. 2024; 38(2):213-228. PMC: 10865771. DOI: 10.1177/02692163231220225. View

19.

Benitez-Rosario M, Ascanio-Leon B . Palliative sedation: beliefs and decision-making among Spanish palliative care physicians. Support Care Cancer. 2019; 28(6):2651-2658. DOI: 10.1007/s00520-019-05086-4. View